COVID-19 vaccine safety checked in cancer immunotherapy patients
NCT ID NCT05025514
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to see if COVID-19 vaccines cause more side effects in cancer patients receiving immunotherapy. Researchers planned to track 125 patients from several hospitals in France, recording any local or systemic side effects. The study was terminated early, so the full results are not available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
COVID-19 vaccines (BNT162b2, mRNA-1273, Oxford/AstraZeneca, Ad26COV2.S)
What this could lead to
If successful, this could show that COVID-19 vaccines are safe for cancer patients on immunotherapy, helping guide vaccination recommendations.
What could go wrong
The study was terminated early with only 125 participants, so results may be incomplete. It was also observational, so it cannot prove cause and effect.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CH d'Auch
Auch, 32008, France
-
CH de Cahors
Cahors, France
-
CHU de Nîmes
Nîmes, Gard, 30029, France
-
Centre Hospitalier d'Albi
Albi, France
-
Clinique des Cèdres - Capio
Cornebarrieu, 31700, France